Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: Experiences of healthcare professionals

Author:

Rehackova Lucia12ORCID,Taylor Roy3ORCID,Lean Mike4ORCID,Barnes Alison5,McCombie Louise4ORCID,Thom George4ORCID,Brosnahan Naomi4ORCID,Leslie Wilma S.4ORCID,Sniehotta Falko F.16ORCID

Affiliation:

1. Policy Research Unit Behavioural Science Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK

2. Policy Innovation Research Unit London School of Hygiene and Tropical Medicine London UK

3. Magnetic Resonance Centre Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

4. Human Nutrition School of Medicine Dentistry and Nursing University of Glasgow Glasgow UK

5. Human Nutrition Research Centre Population Health Sciences Institute Newcastle University Newcastle upon Tyne UK

6. Faculty of Behavioural, Management and Social Sciences (BMS) Twente University Enschede The Netherlands

Funder

Diabetes UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Primary care‐led weight management for remission of type 2 diabetes (DiRECT): an open‐label, cluster‐randomised trial;Lean MEJ;Lancet,2018

2. Durability of a primary care‐led weight‐management intervention for remission of type 2 diabetes: 2‐year results of the DiRECT open‐label, cluster‐randomised trial;Lean MEJ;Lancet Diabetes Endocrinol,2019

3. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM‐I): an open‐label, parallel‐group, randomised controlled trial;Taheri S;Lancet Diabetes Endocrinol,2020

4. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial;Leslie WS;BMC Fam Pract,2016

5. NHS Choices.Very low calorie diets part of NHS action to tackle growing obesity and type 2 diabetes epidemic. Accessed March 26 2021.https://www.england.nhs.uk/2018/11/very‐low‐calorie‐diets‐part‐of‐nhs‐action‐to‐tackle‐growing‐obesity‐and‐type‐2‐diabetes‐epidemic/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3